CHIP-AML22: improving the diagnosis and treatment of paediatric acute myeloid leukemia (AML)
The EU4Health project CHIP-AML22 is working to improve treatment outcomes for children with AML by advancing targeted treatments that reduce the level of toxicity and guarantee more equal outcomes across Europe.
Read the original at the source: https://hadea.ec.europa.eu/news/chip-aml22-improving-diagnosis-and-treatment-paediatric-acute-myeloid-leukemia-aml-2026-09-04_en
Officially imported this from European Health and Digital Executive Agency’s own source. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
Provenance
- Organization
- European Health and Digital Executive Agency — imported from official source
- Official source
- https://hadea.ec.europa.eu/node/2/rss_en RSS
- Imported
- October 03, 2026 20:30
- Versions
- 1 recorded
- Identity
https://hadea.ec.europa.eu/news/chip-aml22-improving-diagnosis-and-treatment-paediatric...